Mint Tower Capital Management’s Surmodics SRDX Stock Holding History

Mint Tower Capital Management’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-30,043	Closed	-$898K	–	285
2025 Q3	$898K	Hold	30,043	–	–	0.11%	109
2025 Q2	$893K	Hold	30,043	–	–	0.13%	80
2025 Q1	$917K	Sell	30,043 -8,000	-21%	-$269K	0.32%	61
2024 Q4	$1.51M	Buy	+38,043	New	+$1.48M	0.37%	47

Other funds holding SRDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mint Tower Capital Management's SRDX Position: Q4 2025 in Review

Mint Tower Capital Management sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 30,043 shares — an estimated $898K sold.

Mint Tower Capital Management first reported a position in SRDX in Q4 2024 and held it in 4 quarters. The position peaked at $1.51M in Q4 2024. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

Mint Tower Capital Management reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
Mint Tower Capital Management sold 30,043 Surmodics shares in Q4 2025, an estimated $898K.
Mint Tower Capital Management first reported a position in Surmodics in Q4 2024 and held it in 4 quarters.
Mint Tower Capital Management's Surmodics position peaked at $1.51M in Q4 2024.
1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on Mint Tower Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.